Capital Bank & Trust CO Grifols Sa Transaction History

Capital Bank & Trust CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $2,152 - $2,531	-118 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $113 - $179	-7 Reduced 5.6%	118 $2,000
Q3 2019 Nov 14, 2019	SELL	$19.85 - $22.76 $3.17 Million - $3.63 Million	-159,544 Reduced 99.92%	125 $3,000
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $157,518 - $188,950	8,955 Added 5.94%	159,669 $3.28 Million
Q1 2019 May 15, 2019	BUY	$18.01 - $20.11 $315,607 - $352,407	17,524 Added 13.16%	150,714 $2.88 Million
Q4 2018 Feb 14, 2019	BUY	$17.44 - $21.53 $201,920 - $249,274	11,578 Added 9.52%	133,190 $2.45 Million
Q3 2018 Nov 14, 2018	BUY	$19.97 - $21.96 $213,998 - $235,323	10,716 Added 9.66%	121,612 $2.6 Million
Q2 2018 Aug 14, 2018	BUY	$20.16 - $24.68 $89,369 - $109,406	4,433 Added 4.16%	110,896 $2.38 Million
Q1 2018 May 15, 2018	BUY	$20.31 - $24.95 $68,261 - $83,856	3,361 Added 3.26%	106,463 $2.26 Million
Q4 2017 Feb 14, 2018	SELL	$20.99 - $23.89 $5.71 Million - $6.5 Million	-272,259 Reduced 72.53%	103,102 $2.36 Million
Q3 2017 Nov 14, 2017	BUY	$20.07 - $21.89 $504,459 - $550,205	25,135 Added 7.18%	375,361 $8.22 Million
Q2 2017 Aug 14, 2017	BUY	N/A	350,226	350,226 $7.4 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.04B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.